Ticker brief

TWST TWIST BIOSCIENCE CORP

Consumer, Non-cyclical · Healthcare-Products

last close
$139.92
1 day
+3.3%
14 days
-12.4%
mkt cap
$6.2B
signals 14d
81
authors 14d
50
crowd 14d
-2.7σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d102% rich · 96 pctile own 1yIV/HV 1.00×
Skew — 25Δ RR 30d-0.069 21 pctile own 1ybalanced vs own range
Net dealer OI (NDOI)+0.41 elevated5-session Δ -0.07 (as of 2026-07-08)
OI alarmquietlast alarm 2026-06-29 (z=3.0)
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-16 · now -0.08 (−1 bearish … +1 bullish)
Who spoke50
authorgradetrader scoresignalsmean sent
@SixSigmaCapitalB+0.1610+0.10
@cfromhertzB-0.964+0.16
@MartyCharginC-0.564+0.19
@epictrades1C+0.014-0.26
@Biotech2k1A+1.114-0.49
@fundmyfundB-0.413-0.32
@NirAoo7C-1.642+0.20
@ConnorJBates_B-0.782+0.38
@LogicalThesisA-1.212-0.15
@cnfinancewatchB-1.232+0.60
@ye4ynB-0.662+0.40
@TickeronC+1.532-0.20
@SandmanMarketsC+0.582+0.70
@wey_how12640C-2.452+0.02
@kovainvestB-0.211+0.65
@RESERVAdeVALORC-1.111+0.25
@StockPatternProC-0.751+0.20
@jom2jpC-1.281+0.40
@StockSavvyShayB-1.051+0.70
@1ChartMasterC-2.951+0.60
@MartinShkreliB+0.881-0.85
@TheLAPurchaserA+0.301-0.70
@nikkei_4451B-1.971+0.15
@ANDYmoonC-2.411+0.25
@BaldwinDunas·-0.541+0.00
Recent signals30of 81 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-16@labubu_trader-0.40Reports selling half on a bounce and stopping out the remainder after technical support failed.+5.4%
2026-10-16@Tickeron+0.15Summarizes widely dispersed analyst targets for Twist Bioscience.+5.4%
2026-10-16@SixSigmaCapital+0.00Seeks future asymmetric trades in consumer, rate-sensitive, minerals and healthcare sectors after a TWST recap.+5.4%
2026-10-15@wey_how12640-0.60Discloses portfolio deletions and new positions, with additional top-ups and trimming across the portfolio.-3.2%
2026-10-14@wey_how12640+0.65Starting a TWST position and will reassess if it decisively loses the 50-day moving average. — Announces a starter position based on a genomics pick-and-shovel thesis and 50DMA support.-5.6%
2026-10-14@ElliottWaveSage+0.55Explains why Elliott-wave counts alone can fail and cites TWST and SPHR as trends that extended violently higher.-5.6%
2026-10-13@Biotech2k1-0.65Labels the named biotech stocks as bubble names and excludes them from bargains.-7.5%
2026-10-13@HedgeFundTips+0.00Shares an equal-weight chart of biotech earnings estimates and revisions.-7.5%
2026-10-13@tenet_research+0.70Ranks leading 2026 year-to-date stock returns with explicit percentage gains.-7.5%
2026-10-13@StonkTrump+0.65Cites active call buying and a second test of the 50 EMA as a favorable long setup.-7.5%
2026-10-13@kiantrades+0.50Reports $199K whale buying of TWST calls at the 50-day average.-7.5%
2026-10-10@epictrades1+0.25Notes both genomics stocks bounced just above their 50-day averages and identifies the lows as important.-12.4%
2026-10-09@PortfolioArmor+0.00Links a recap of trades exited during the week without stating individual results.-12.4%
2026-10-09@SandmanMarkets+0.70Buy TWST despite the recent sharp selloff — Explicit buy recommendation based on OBV support and two hidden bullish divergences-12.4%
2026-10-09@SandmanMarkets+0.70Buy LPX, BEAM, CCC and TWST; watch CRNT and HXL — Publishes explicit buy and watch lists; ticker cap retains buys and first two watches-12.4%
2026-10-09@SixSigmaCapital+0.80Reports closing TWST for a seven-bagger that generated about two-thirds of YTD gains.-12.4%
2026-10-09@LogicalThesis+0.20Suggests the referenced move is being driven by strength in MRNA and TWST.-12.4%
2026-10-09@fundmyfund-0.70Reports TWST falling 35% from a breakout to its 50-day average in three days.-12.4%
2026-10-08@Biotech2k1+0.10Quantifies broad biotech drawdowns and says three stocks are supporting the index.-8.0%
2026-10-08@KeithTradeSmith+0.75AI-driven genomics is presented as an early-stage secular theme with further upside after pullbacks.-8.0%
2026-10-08@artinmemes+0.35The author presents a bullish basket of life-science suppliers positioned around the AI-drug-discovery bottleneck.-8.0%
2026-10-08@SixSigmaCapital-0.25Author closed the remaining TWST position after a weighted sixfold gain.-8.0%
2026-10-08@cnfinancewatch+0.45Presents a long-term biotech growth basket spanning genomics, AI drug discovery and related platforms.-8.0%
2026-10-07@epictrades1-0.20Says recent selloffs need context after huge runs and expects time and base building.-10.1%
2026-10-07@_TP888+0.45Reports $234K of TWST calls bought at the offer.-10.1%
2026-10-07@MMatters22596+0.40Presents a long-term biotech basket organized by genomics and AI drug-discovery layers.-10.1%
2026-10-07@Biotech2k1-0.65Calls MRNA and TWST examples of low-quality stocks trading near all-time highs.-10.1%
2026-10-07@GassionGreta-0.65Knife metaphor conveys continued bearish price action in TWST.-10.1%
2026-10-07@Biotech2k1-0.75Calls AI-linked and vaccine biotech names overhyped meme stocks reminiscent of the genomics bubble.-10.1%
2026-10-06@AntonLaVay-0.50Biotech's crash is framed as the first sign of broader liquidation in crowded winners and weakening breadth.-16.2%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.